Ventolin vs Symbicort
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| NZ Ventolin | NZ Symbicort | |
|---|---|---|
| Generic name | salbutamol | budesonide/formoterol |
| Drug class | Short-Acting Beta-2 Agonist (SABA) | Inhaled Corticosteroid + LABA |
| Treats | Asthma, bronchospasm | Asthma, COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | GSK | AstraZeneca |
| Year approved | 1981 | 2002 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $3M | $3M |
| Common side effects | Tremor, Fast heartbeat, Nervousness, Headache | Thrush, Headache, Tremor, Throat irritation |
Symbicort
Frequently asked questions
Is Ventolin or Symbicort better?
Neither is universally "better." Ventolin (salbutamol) and Symbicort (budesonide/formoterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Ventolin and Symbicort?
Ventolin is a Short-Acting Beta-2 Agonist (SABA) made by GSK, while Symbicort is a Inhaled Corticosteroid + LABA made by AstraZeneca. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Ventolin has the larger estimated TV advertising budget of the two.